miR-34c-3p targets CDK1 a synthetic lethality partner of KRAS in non-small cell lung cancer.
Palma F, Affinito A, Nuzzo S, Roscigno G, Scognamiglio I, Ingenito F, Martinez L, Franzese M, Zanfardino M, Soricelli A, Fiorelli A, Condorelli G, Quintavalle C.
Palma F, et al. Among authors: zanfardino m.
Cancer Gene Ther. 2021 May;28(5):413-426. doi: 10.1038/s41417-020-00224-1. Epub 2020 Sep 18.
Cancer Gene Ther. 2021.
PMID: 32948832
Free PMC article.